glp-1 analog drugs Receptor Agonists as Treatments for Type 2 Diabetes Glucagon-like peptide-1 - Wikipedia
Description
115 Additionally, TZDs have been shown to be the least effective in diminishing BMI
Do they actually work
[39] analyzed the uncertain association between glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancer
There are currently no specific agents for NAFLD [103]
